---
title: "180 LIFE SCIENCES CORP C/WTS 07/11/2025(TO PUR COM) | 10-Q: FY2025 Q1 EPS: USD -0.67"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/240447415.md"
datetime: "2025-05-15T20:27:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/240447415.md)
  - [en](https://longbridge.com/en/news/240447415.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/240447415.md)
---

# 180 LIFE SCIENCES CORP C/WTS 07/11/2025(TO PUR COM) | 10-Q: FY2025 Q1 EPS: USD -0.67

EPS: As of FY2025 Q1, the actual value is USD -0.67.

### Segment Revenue

-   The company has not generated any revenues and has incurred significant losses since inception.

### Operational Metrics

-   **Net Loss**: The company reported a net loss of $2,369,232 for the three months ended March 31, 2025, compared to a net loss of $1,069,744 for the same period in 2024, representing an increase in net loss of $1,299,488 or 121%.
-   **Operating Expenses**: Total operating expenses for the three months ended March 31, 2025, were $2,372,968, compared to $2,092,468 for the same period in 2024.
-   **Research and Development Expenses**: R&D expenses were $240,905 for the three months ended March 31, 2025, compared to $365,186 for the same period in 2024, representing a decrease of $124,281 or 34%.
-   **General and Administrative Expenses**: G&A expenses were $1,996,608 for the three months ended March 31, 2025, compared to $1,556,740 for the same period in 2024, representing an increase of $439,868 or 28%.

### Cash Flow

-   **Net Cash Used in Operating Activities**: For the three months ended March 31, 2025, cash used in operating activities was $853,723, compared to $1,033,417 for the same period in 2024.
-   **Net Cash Used in Financing Activities**: Cash used in financing activities was $3,320 for the three months ended March 31, 2025, compared to $264,394 for the same period in 2024.

### Unique Metrics

-   **Accumulated Deficit**: As of March 31, 2025, the company had an accumulated deficit of $143,892,576.

### Future Outlook and Strategy

-   **Core Business Focus**: The company plans to strategically enter into the online gaming industry, utilizing its acquired blockchain casino technology platform to establish a blockchain-based business aimed at the global iGaming market.
-   **Non-Core Business**: The company is evaluating strategic options for its TNF and CBD programs, including potential sale or disposition, return of these assets to the underlying owners, or other strategic alternatives.
-   **Priority**: The company expects to invest a significant amount of capital to commercialize its iGaming assets and fund research and development.

### Related Stocks

- [ATNFW.US](https://longbridge.com/en/quote/ATNFW.US.md)
- [ETHZW.US](https://longbridge.com/en/quote/ETHZW.US.md)

## Related News & Research

- [Restart Life Sciences Becomes Revenue Producer With Holy Crap Foods Acquisition](https://longbridge.com/en/news/277213976.md)